Several Ebola vaccine are being developed in many countries, including USA, Germany, Switzerland and Canada, but none had yet been approved by the United States Food and Drug Administration (FDA) for clinical use in humans. The latest news is the suspension of the clinical trial of a vaccine at the University Hospital of Geneva. Why? Some of the volunteers who participated experienced muscle and joint pain, symptoms which were not among the expected side effects.
In the meanwhile, Christmas and New Year gatherings have been banned by Sierra Leone government throughout the whole country: authorities fear the Ebola virus will spread to rural villages as people go home to celebrate. Officials in Liberia have postponed - again - senatorial elections until the end of this week, while some urged calling off the vote for fear the results would not be credible. Here, virus Ebola has killed nearly 3,200 people this year and isn't stopping.